Synthesis, characterization, and thermodynamic study of a polyvalent lytic peptide-polymer conjugate as novel anticancer agent

Bioconjugate Chemistry

Volumn 21, Issue 11, 2010, Pages 2055-2064

  Zhong, Jieying ^a   Chau, Ying ^b  

^a Bioengineering Graduate Program   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; LIPID BILAYERS; PEPTIDES;

ANTI-CANCER AGENTS; CHARACTERIZATION STUDIES; CHEMOTHERAPEUTIC AGENTS; FREE PEPTIDES; HEXAPEPTIDES; LYTIC PEPTIDES; MULTIDRUG RESISTANCE; POLYMER CONJUGATE; SYNTHESISED; THERMODYNAMIC STUDIES;

THERMODYNAMIC PROPERTIES;

ANTINEOPLASTIC AGENT; DEXTRAN; LYSYLTRYPTOPHYLLYSYLTRYPTOPHYLLYSYLTRYPTOPHAN; PEPTIDE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL MEMBRANE; CONJUGATE; CONTROLLED STUDY; DRUG BINDING; DRUG CONJUGATION; DRUG DESIGN; DRUG POTENCY; DRUG STABILITY; DRUG SYNTHESIS; ENTHALPY; ENTROPY; HEMOLYSIS; HUMAN; HUMAN CELL; LIPID BILAYER; MOLECULAR INTERACTION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; THERMODYNAMICS;

EID: 78649270296     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc1002899     Document Type: Article

References (26)

1. Gottesman, M. M., Fojo, T., and Bates, S. E. (2002) Multidrug resistance in cancer: Role of ATP-dependent transporters Nat. Rev. Cancer 2, 48-58
2. Hancock, R. E. W. and Sahl, H. G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat. Biotechnol. 24, 1551-1557
3. Leuschner, C. and Hansel, W. (2004) Membrane disrupting lytic peptides for cancer treatments Curr. Pharm. Des. 10, 2299-2310
4. Papo, N. and Shai, Y. (2005) Host defense peptides as new weapons in cancer treatment Cell. Mol. Life Sci. 62, 784-790
5. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms Nature 415, 389-395
6. Shai, Y. (2002) Mode of action of membrane active antimicrobial peptides Biopolymers 66, 236-248
7. Matsuzaki, K. (1999) Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes Biochim. Biophys. Acta 1462, 1-10
8. Mammen, M., Choi, S. K., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. 37, 2755-2794
9. Arnusch, C. J., Branderhorst, H., De Kruijff, B., Liskamp, R. M. J., Breukink, E., and Pieters, R. J. (2007) Enhanced membrane pore formation by multimeric/oligomeric antimicrobial peptides Biochemistry 46, 13437-13442
10. Liu, Z. G., Deshazer, H., Rice, A. J., Chen, K., Zhou, C. H., and Kallenbach, N. R. (2006) Multivalent antimicrobial peptides from a reactive polymer scaffold J. Med. Chem. 49, 3436-3439
11. Tam, J. P., Lu, Y. A., and Yang, J. L. (2002) Antimicrobial dendrimeric peptides Eur. J. Biochem. 269, 923-932
12. Maeda, H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects, Bioconjugate Chem. 21, 797 - 802.
13. Snyder, S. L. and Sobocinski, P. Z. (1975) An improved 2,4,6 trinitrobenzenesulfonic acid method for the determination of amines Anal. Biochem. 64, 284-288
14. Seelig, J. (1997) Titration calorimetry of lipid-peptide interactions Biochim. Biophys. Acta 1331, 103-116
15. Chen, P. W., Shyu, C. L., and Mao, F. C. (2003) Antibacterial activity of short hydrophobic and basic-rich peptides Am. J. Vet. Res. 64, 1088-1092
16. Schibli, D. J., Epand, R. F., Vogel, H. J., and Epand, R. M. (2002) Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions Biochem. Cell Biol. 80, 667-677
17. Almeida, P. F. and Pokorny, A. (2009) Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics Biochemistry 48, 8083-8093
18. Ohsaki, Y., Gazdar, A. F., Chen, H. C., and Johnson, B. E. (1992) Antitumor-activity of magainin analogs against human lung-cancer cell-lines Cancer Res. 52, 3534-3538
19. Seelig, J. (2004) Thermodynamics of lipid-peptide interactions Biochim. Biophys. Acta 1666, 40-50
20. Dathe, M., Nikolenko, H., Klose, J., and Bienert, M. (2004) Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides Biochemistry 43, 9140-9150
21. Haug, B. E., Stensen, W., Stiberg, T., and Svendsen, J. S. (2004) Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides J. Med. Chem. 47, 4159-4162
22. Sundriyal, S., Sharma, R. K., Jain, R., and Bharatam, P. V. (2008) Minimum requirements of hydrophobic and hydrophilic features in cationic peptide antibiotics (CPAs): pharmacophore generation and validation with cationic steroid antibiotics (CSAs) J. Mol. Model. 14, 265-278
23. Sato, H. and Felix, J. B. (2006) Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides Biochim. Biophys. Acta 1758, 1245-1256
24. Yeagle, P. L. (1985) Cholesterol and the cell membrane, Biochim. Biophys. Acta 822.
25. Araki, K. and Rifkind, J. M. (1980) Erythrocyte membrane cholesterol: An explanation of the aging effect on the rate of hemolysis. Life Sci. 26.
26. Sarah, R., Dennison, M. W., Harris, F., and Phoenix, D. A. (2006) Anticancer α-helical peptides and structure/function relationships underpinning their interactions with tumor cell membranes, Curr. Protein Pept. Sci. 7.